Stock Price Quote

UNJHA FORMULATIONS LTD.

NSE : NABSE : 531762ISIN CODE : INE576D01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE31.81-1.65 (-4.93 %)
PREV CLOSE ( ) 33.46
OPEN PRICE ( ) 33.46
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 15666
TODAY'S LOW / HIGH ( )31.79 34.99
52 WK LOW / HIGH ( ) 10.5533.47
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1994
Management Info
Jashodaben S Patel - Chairman Krutiben M Patel - Managing Director
Registered Office

Address Khali Char Rasta,State Highway, ,
Sidhpur,
Gujarat-384151

Phone 02767- 282395 / 282396 / 282464 / 9825069590 / 9825017696

Email info@unjhaformulations.com

Website www.unjhaformulations.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE

NEWS

08May Unjha Formulations informs about board
Unjha Formulations has informed that a meeting of Board of Directors of..
14Mar Unjha Formulations informs about chang
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
13Jul Unjha Formulations informs about book
Pursuant to the SEBI (Listing Obligation and Disclosure Requirements) Re..
18Apr Unjha Formulations informs about board
Unjha Formulations has informed that the meeting of the Board of Directo..
28Aug Unjha Formulations informs about filin
Unjha Formulations has informed that 27th Annual General Meeting of Memb..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit-1.762.78000000000001
Gross Profit -0.0199999999999992 4.52000000000001
Operating Profit 0.7100000000000015.89000000000001
Net Sales 44.39185.08

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Alkem Laboratories (BSE)
peergroup  5460.90 (2.86%)
M.Cap ( in Cr)65162.93
Glaxosmithkline Phar (BSE)
peergroup  2474.50 (4.09%)
M.Cap ( in Cr)41843.29
Gland Pharma (BSE)
peergroup  1880.90 (4.76%)
M.Cap ( in Cr)30949.11
Coral Laboratories (BSE)
peergroup  451.20 (20.00%)
M.Cap ( in Cr)161.20
Pfizer (BSE)
peergroup  4567.85 (1.64%)
M.Cap ( in Cr)20815.22

Shareholding Pattern

NON-INSTITUTION 63.08%
PROMOTERS 36.92%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Unjha Formulations Ltd.

Unjha Formulations Ltd. was incorporated in the year 1994. Its today's share price is 31.81. Its current market capitalisation stands at Rs 14.24 Cr. In the latest quarter, company has reported Gross Sales of Rs. 131.54 Cr and Total Income of Rs.131.84 Cr. The company's management includes Mustufa Najmuddin Jodhpurwala, Jitendra P Limbachiya, Hasmukh S Darji, Esha Mayank Patel, Jigar Ray, Krutiben M Patel, Jashodaben S Patel.

It is listed on the BSE with a BSE Code of 531762 , NSE with an NSE Symbol of and ISIN of INE576D01015. It's Registered office is at Khali Char Rasta,State Highway, Sidhpur-384151, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Kantilal Manilal Shah & Co, Milind Shah & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.